Delivery Order SPE2DB22D1106-SPE2DB25FDJS0
Award Date
10/31/24
Potential Completion Date
11/1/24
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 8 mg tablets. The $2,768.58 contract has an ultimate completion date of September 11, 2024. No set-aside designation was used. Amerisourcebergen holds a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565614740 Ondansetron ODT 4 mg tablets. The contract has a total ceiling value of $2,166.87 and an ultimate completion date of August 29, 2024. AmerisourceBergen was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $12,727.71 and a completion date of July 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for delivering a wide range of medical commodities to support military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, with a ceiling value of $6,305.60 and a completion date of January 3, 2025. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Ondansetron ODT 8 mg tablets. The contract, valued at $6,586.56, is a firm fixed-price delivery order with a completion date of July 19, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,719,883 units of the medication Ondansetron ODT 8 mg tablets, with a ceiling value of $7,947.35 and a completion date of December 16, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 8 mg tablets. The contract, valued at $5,885.04, has a firm fixed price and a completion date of January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $17,404.42 and an ultimate completion date of August 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for providing the pharmaceutical products to the government under this contract. This award...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 8 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $3,313.82 and an ultimate completion date of August 19, 2024. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025 for delivering a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $16,125.04 contract is for the delivery of 4566378176 units of the drug Ondansetron ODT 4 mg Tablet 30s. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...